Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -1.87% is 115% below its 1-year average of 12.36%, around the middle of its 1-year range (-23.47%–45.54%).
115.12% below its 12-month average of 12.36%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 19.47%.
GROSS MARGIN
-1.87%
GROSS MARGIN AVG TTM
12.36%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-115.12%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
-104.36%
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Gross Margin
-1.87%
TTM Avg
12.36%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14M
Gross Margin
10.32%
TTM Avg
11.11%
3Y Avg
16.34%
5Y Avg
16.34%
Market Cap
$888387.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$878396.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$787624.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
4.91%
5Y Avg
3.27%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | -1.87% | 12.36% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | 10.32% | 11.11% | 16.34% | 16.34% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 0.00% | 0.00% | 0.00% | 16.67% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | 13.74% | 16.67% | 17.59% | 25.81% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 0.00% | 0.00% | 4.91% | 3.27% |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-1.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 19.47% |
| 2026-03-31 | 20.28% |
| 2025-12-31 | -23.47% |
| 2025-09-30 | 45.54% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
